Shop our best sellers.

What the Human Research Shows on NMN

The evidence that NMN raises blood NAD in humans is solid, and the evidence that it produces specific functional improvements is real but selective. However, lifespan extension in humans has not been demonstrated, partly because human lifespans are long, and the research is young.

Here’s what the data shows:

• NAD elevation: Okabe et al. (Frontiers in Nutrition, 2022) gave 250 mg/day oral NMN to healthy adults for 4 weeks and measured blood NAD levels. The increase was roughly 40%, with no adverse events reported.
• Insulin sensitivity in prediabetic women: Yoshino et al. (Science, 2021) studied 250 mg/day NMN over 10 weeks in postmenopausal women with prediabetes. The group showed improved muscle insulin sensitivity compared to placebo, a meaningful marker for metabolic health.
• Physical performance in older adults: Igarashi et al. (Aging and Mechanisms of Disease, 2022) gave 250 mg/day NMN to healthy men aged 65 and older for 12 weeks. Blood NAD rose, and gait speed and grip strength showed nominal improvements, though the effect sizes were modest.
• Aerobic capacity in runners: Liao et al. (Journal of the International Society of Sports Nutrition, 2021) found dose-dependent improvements in oxygen uptake at ventilatory threshold in amateur runners at doses ranging from 300-1,200 mg/day over 6 weeks.
• Aerobic capacity and walking distance in middle-aged adults: Yi et al. (GeroScience, 2022) studied 600 mg/day NMN in healthy middle-aged adults and found improvements in aerobic capacity and walking distance, with a clear dose-response pattern at doses above 300 mg/day.
  

An honest caveat is that blood NAD is a biomarker. Improved insulin sensitivity or walking speed are functional outcomes, and that's better. But these are single studies, often in small groups, and none demonstrate an extended human lifespan. The effect on lifespan remains theoretical, based on aging models in other organisms.

Does the Form of NMN Matter?

Nearly all the human trials cited above used oral capsules or tablets. That's the clinically validated delivery method.

You can find liposomal NMN, sublingual NMN, and intranasal NMN marketed online with claims about superior absorption, but those formats lack the human trial base that oral NMN has. Their dosing is based on mechanistic theory, not human study data. Until they're tested in people at defined doses, they remain unproven relative to the oral capsule.

The mechanism by which oral NMN is absorbed is still being refined. One candidate is the SLC12A8 gut transporter (Grozio et al., Nature Metabolism, 2019), which is also an area of active research. 

BioPerine (black pepper extract) is included in many formulas based on its ability to enhance the absorption of other compounds, though NMN-specific absorption data in humans is limited.

The point is, if you're taking NMN to match the dosing studied in humans, take it in the form that's actually been studied in humans, i.e., an oral capsule.

How Much NMN Should You Take?

The studied effective range is 250 to 900 mg per day, with most benefits demonstrated at 250-600 mg.

250 mg daily is the dose used in most efficacy trials. Okabe, Yoshino, and Igarashi all used this amount and found NAD elevation and some functional improvement.

600 mg daily is the dose used in Yi et al, which showed clear improvements in aerobic capacity and walking distance.

Up to 1,200 mg daily was tested safely over 6 weeks in Liao et al. without serious adverse events, though no clear additional benefit was shown above 600 mg.

Omre delivers 500 mg per capsule, so it is squarely in the middle of the validated range and in line with doses in published research.

Doses below 250 mg are likely subtherapeutic because you're unlikely to replicate the NAD elevation seen in the trials. Doses above 900 mg lack specific human validation. Animal models and in vitro studies suggest diminishing returns, but we don't have human data to be certain.

What Makes a Quality NMN Supplement (and How Omre Delivers)

The following characteristics make a quality NMN supplement:

• Clinically studied dose. The effective range is 250-600 mg daily based on published human trials. Omre provides 500 mg of >99% purity NMN per capsule.

• A SIRT1 activator on the same pathway. NAD is the fuel that powers sirtuins, enzymes that regulate metabolism, inflammation, and cellular repair. By raising NAD (via NMN), you enable sirtuins to function at higher efficiency. Trans-resveratrol is a well-documented activator of SIRT1. By pairing an NAD precursor (NMN) with a SIRT1 activator (resveratrol), the formula supports both the supply of NAD and the sirtuin activity that draws on it

• Verifiable third-party testing. This is where most NMN products fail. An independent analysis of 22 commercial NMN products commissioned by ChromaDex and published in 2021 found that 64% of products contained less than 1% of the labeled NMN amount, and NMN was undetectable in 14% of samples. A peer-reviewed corroboration appears in Sandalova et al. (GeroScience, 2024), which analyzed 18 commercial NMN products and found deviations ranging from +28.6% to -100% of labeled content. 

• Omre publishes a batch-specific certificate of analysis for every lot, confirmed by independent HPLC testing. You can verify what's actually in the bottle.
  
  
• Manufacturing transparency. GMP-certified and FDA-registered facility in the United States. Dual-stage testing at both the raw material and finished product level.

NMN vs. NAD: Why You Can't Just Take NAD

Oral NAD (the finished molecule) doesn't work as a supplement. NAD is large, charged, and unstable in stomach acid. It's degraded during digestion before absorption. This is why no one sells oral NAD; it's biochemically futile.

NMN is smaller and uncharged. It crosses the intestinal epithelium via specific transporters and converts to NAD intracellularly in a single enzymatic step. This is why NMN is the precursor of choice in supplemental form.

NMN vs. NR: Two Precursors, Two Evidence Bases

Both NMN and nicotinamide riboside (NR) are NAD precursors with human trial data, so neither can be dismissed. NR has the longest research record, starting from the earliest human studies that date to 2012 (Brenner, 2004, established the mechanism in yeast). Cardiovascular data on NR is strong, particularly from Martens et al. (Nature Communications, 2018), which showed improvements in arterial stiffness in healthy middle-aged and older adults.

NMN has more recent momentum. The trials cited above show consistent effects on metabolic function, aerobic capacity, and sleep outcomes, where NR's evidence is thinner. NMN sits one step closer to NAD than NR does biochemically, which some researchers hypothesize could yield faster or more efficient effects, though this remains unproven in humans.

The honest answer is that neither is dramatically superior. They're two different precursors with overlapping but distinct evidence bases. Which you choose depends on your outcome of interest and comfort with slightly older versus slightly newer research.

Is NMN Safe? FDA Status and Side Effects

In 2022, the FDA excluded NMN from the dietary supplement definition, treating it as a new molecular entity requiring separate approval. In September 2025, the FDA reversed course and confirmed NMN as a lawful dietary supplement ingredient.

NMN has been tested up to 1,200 mg/day for 6 weeks (Liao et al.) with good overall tolerability. The most common side effects reported in trials are mild, comprising occasional gastrointestinal upset, transient headache, and fatigue. Serious adverse events have not been documented in published trials.

Long-term multi-year safety data in humans does not exist since the longest published trial is 12 weeks (Igarashi et al.) Animal studies support safety at much higher doses relative to body weight, but human long-term data, such as 5 years or 10 years, are simply not available yet.

NAD fuels cellular energy, including in cancer cells. People with active cancer, a personal history of cancer, or those undergoing cancer treatment should consult a physician before starting NMN.

People who are pregnant or breastfeeding, those taking blood thinners, and those on blood-pressure medication should also consult a doctor before starting, as interaction data is sparse.